• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-150 可作为诊断生物标志物,并参与帕金森病的炎症发病机制。

MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease.

机构信息

Department of Neurology, Shengli Oilfield Central Hospital, Dongying, Shandong, China.

出版信息

Mol Genet Genomic Med. 2020 Apr;8(4):e1189. doi: 10.1002/mgg3.1189. Epub 2020 Feb 20.

DOI:10.1002/mgg3.1189
PMID:32077254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196454/
Abstract

BACKGROUND

Dysregulation of microRNAs (miRNAs) has been reported to be involved in the neuroinflammatory pathogenesis of PD. This study aimed to investigate the serum expression of microRNA-150 (miR-150) in Parkinson's disease (PD) patients and further uncover the regulatory effect of miR-150 on neuroinflammation.

METHODS

Quantitative Real-Time PCR was used to measure the expression of miR-150. A receiver operating characteristic curve was applied to evaluate the diagnostic value of miR-150. The effect of miR-150 on neuroinflammation was analyzed by examining its correlation with proinflammatory cytokines and gain-of-function experiments in microglia treated with LPS.

RESULTS

Serum miR-150 expression was downregulated in PD patients compared with the healthy controls, and served as a candidate diagnostic biomarker for the screening of PD cases. Negative correlation was found between miR-150 levels and the levels of procytokines in PD patients. By the treatment of LPS, microglia BV2 cells had a reduced expression of miR-150, and the enhanced neuroinflammatory responses were inhibited by the overexpression of miR-150. AKT3 was verified as a target of miR-150 in BV2 cells.

CONCLUSION

All the data of this study revealed that the decreased serum miR-150 serves as a potential diagnostic biomarker. The methods to increase miR-150 expression may have a beneficial effect in PD via suppressing the neuroinflammation by targeting AKT3.

摘要

背景

已有研究报道,微小 RNA(miRNA)的失调与 PD 的神经炎症发病机制有关。本研究旨在探讨帕金森病(PD)患者血清 miR-150 的表达情况,并进一步揭示 miR-150 对神经炎症的调控作用。

方法

采用实时定量 PCR 检测 miR-150 的表达。应用受试者工作特征曲线评估 miR-150 的诊断价值。通过 LPS 处理的小胶质细胞中检测促炎细胞因子及其功能获得实验来分析 miR-150 对神经炎症的影响。

结果

与健康对照组相比,PD 患者血清 miR-150 表达下调,可作为 PD 病例筛查的候选诊断生物标志物。PD 患者 miR-150 水平与前细胞因子水平呈负相关。经 LPS 处理后,BV2 细胞中 miR-150 表达减少,而过表达 miR-150 可抑制增强的神经炎症反应。AKT3 被验证为 BV2 细胞中 miR-150 的靶标。

结论

本研究的所有数据表明,血清 miR-150 表达降低可作为一种潜在的诊断生物标志物。通过靶向 AKT3 增加 miR-150 的表达可能对 PD 具有有益的治疗作用,从而抑制神经炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/817cb7cbe139/MGG3-8-e1189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/284169e3b266/MGG3-8-e1189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/8977b1ceb1d8/MGG3-8-e1189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/f403a38de662/MGG3-8-e1189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/817cb7cbe139/MGG3-8-e1189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/284169e3b266/MGG3-8-e1189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/8977b1ceb1d8/MGG3-8-e1189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/f403a38de662/MGG3-8-e1189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3f/7196454/817cb7cbe139/MGG3-8-e1189-g004.jpg

相似文献

1
MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease.MicroRNA-150 可作为诊断生物标志物,并参与帕金森病的炎症发病机制。
Mol Genet Genomic Med. 2020 Apr;8(4):e1189. doi: 10.1002/mgg3.1189. Epub 2020 Feb 20.
2
Diagnostic Performance of miR-485-3p in Patients with Parkinson's Disease and its Relationship with Neuroinflammation.miR-485-3p 在帕金森病患者中的诊断性能及其与神经炎症的关系。
Neuromolecular Med. 2022 Jun;24(2):195-201. doi: 10.1007/s12017-021-08676-w. Epub 2021 Jul 19.
3
MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.miR-485-3p 通过靶向 AKT3 调节神经元细胞活力和神经炎症,可作为阿尔茨海默病的生物标志物和治疗靶点。
Mol Genet Genomic Med. 2021 Jan;9(1):e1548. doi: 10.1002/mgg3.1548. Epub 2020 Nov 21.
4
MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.MicroRNA-124 调节 p62/p38 的表达,促进帕金森病炎症发病机制中的自噬。
FASEB J. 2019 Jul;33(7):8648-8665. doi: 10.1096/fj.201900363R. Epub 2019 Apr 17.
5
Deregulated miR-384 serves as a biomarker in neonatal hypoxic-ischemic encephalopathy and alleviates microglia-mediated neuroinflammation.失调的 miR-384 可作为新生儿缺氧缺血性脑病的生物标志物,并减轻小胶质细胞介导的神经炎症。
Mol Biol Rep. 2020 Jul;47(7):5411-5420. doi: 10.1007/s11033-020-05631-z. Epub 2020 Jul 3.
6
Serum miR-221 serves as a biomarker for Parkinson's disease.血清miR-221可作为帕金森病的生物标志物。
Cell Biochem Funct. 2016 Oct;34(7):511-515. doi: 10.1002/cbf.3224.
7
MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.血清中外泌体样微泡中帕金森病的微小RNA生物标志物
Neurosci Lett. 2017 Mar 22;644:94-99. doi: 10.1016/j.neulet.2017.02.045. Epub 2017 Feb 20.
8
MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.MicroRNA-190 通过 Nlrp3 减轻 MPTP 诱导的帕金森病小鼠模型中的神经元损伤并抑制神经炎症。
J Cell Physiol. 2019 Dec;234(12):23379-23387. doi: 10.1002/jcp.28907. Epub 2019 Jun 24.
9
Serum microRNA expression levels in Turkish patients with Parkinson's disease.土耳其帕金森病患者血清 microRNA 表达水平。
Int J Neurosci. 2021 Dec;131(12):1181-1189. doi: 10.1080/00207454.2020.1784165. Epub 2020 Jun 25.
10
A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.一组四种血清微小RNA减少作为早期帕金森病的新型生物标志物。
Biomarkers. 2016;21(2):129-37. doi: 10.3109/1354750X.2015.1118544. Epub 2015 Dec 3.

引用本文的文献

1
Translating Exosomal microRNAs from Bench to Bedside in Parkinson's Disease.将帕金森病中外泌体微小RNA从实验室转化到临床应用
Brain Sci. 2025 Jul 16;15(7):756. doi: 10.3390/brainsci15070756.
2
Multi-omics and AI-driven advances in miRNA-mediated hair follicle regulation in cashmere goats.多组学与人工智能驱动的绒山羊中miRNA介导的毛囊调控研究进展
Front Vet Sci. 2025 Jul 9;12:1635202. doi: 10.3389/fvets.2025.1635202. eCollection 2025.
3
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson's disease.

本文引用的文献

1
MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN.微小RNA-204可能通过靶向KLLN参与缺氧缺血性脑病的发病机制。
Exp Ther Med. 2019 Nov;18(5):3299-3306. doi: 10.3892/etm.2019.7936. Epub 2019 Aug 26.
2
Decreased Serum , , , and in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis.自身免疫性糖尿病患者血清中[具体物质1]、[具体物质2]、[具体物质3]和[具体物质4]水平降低:诊断的潜在生物标志物及可能参与发病机制
Int J Endocrinol. 2019 Sep 9;2019:8406438. doi: 10.1155/2019/8406438. eCollection 2019.
3
MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3.
微小RNA的上调与帕金森病中内源性逆转录病毒K(HERV-K)表达的下调相关。
J Neurovirol. 2024 Dec;30(5-6):550-555. doi: 10.1007/s13365-024-01234-7. Epub 2024 Oct 18.
4
MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.微小RNA在帕金森病中的调控及其作为诊断和治疗靶点的潜在作用。
NPJ Parkinsons Dis. 2024 Oct 5;10(1):186. doi: 10.1038/s41531-024-00791-2.
5
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.帕金森病中的神经炎症:聚焦于微小RNA与小胶质细胞之间的关系
Front Cell Neurosci. 2024 Jul 26;18:1429977. doi: 10.3389/fncel.2024.1429977. eCollection 2024.
6
Mitochondria-Associated MicroRNAs and Parkinson's Disease.线粒体相关的微小RNA与帕金森病
Neurosci Insights. 2024 May 24;19:26331055241254846. doi: 10.1177/26331055241254846. eCollection 2024.
7
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders.用于神经系统疾病的临床和临床前试验中的肿瘤抑制性微小RNA
Pharmaceuticals (Basel). 2024 Mar 27;17(4):426. doi: 10.3390/ph17040426.
8
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson's Disease.解析帕金森病失调的细胞信号通路、遗传和表观遗传之谜。
Mol Neurobiol. 2024 Nov;61(11):8928-8966. doi: 10.1007/s12035-024-04128-1. Epub 2024 Apr 4.
9
Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson's disease.用于检测快速眼动睡眠行为障碍和帕金森病的外泌体微小RNA候选生物标志物。
NPJ Parkinsons Dis. 2024 Jan 10;10(1):18. doi: 10.1038/s41531-023-00628-4.
10
Investigating microRNAs as biomarkers in disorders of consciousness: a longitudinal multicenter study.探讨意识障碍中 microRNAs 作为生物标志物:一项纵向多中心研究。
Sci Rep. 2023 Oct 27;13(1):18415. doi: 10.1038/s41598-023-45719-7.
miR-150 通过靶向 AKT3 减轻 LPS 诱导的急性肺损伤。
Int Immunopharmacol. 2019 Oct;75:105794. doi: 10.1016/j.intimp.2019.105794. Epub 2019 Aug 6.
4
Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.虎杖苷通过调节 AKT/GSK3β-Nrf2/NF-κB 信号通路预防脂多糖(LPS)诱导的帕金森病。
Front Immunol. 2018 Nov 5;9:2527. doi: 10.3389/fimmu.2018.02527. eCollection 2018.
5
Parkinson's disease pathogenesis, evolution and alternative pathways: A review.帕金森病的发病机制、演变和替代途径:综述。
Rev Neurol (Paris). 2018 Dec;174(10):699-704. doi: 10.1016/j.neurol.2017.12.003. Epub 2018 Aug 18.
6
Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.循环 miR-127-3p 作为额颞叶痴呆鉴别诊断的潜在生物标志物。
J Alzheimers Dis. 2018;65(2):455-464. doi: 10.3233/JAD-180364.
7
Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.长链非编码 RNA SNHG1 通过调控 miR-7/NLRP3 通路促进帕金森病中的神经炎症。
Neuroscience. 2018 Sep 15;388:118-127. doi: 10.1016/j.neuroscience.2018.07.019. Epub 2018 Jul 18.
8
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.MicroRNA-30e 通过靶向 Nlrp3 调节 MPTP 帕金森病模型中的神经炎症。
Hum Cell. 2018 Apr;31(2):106-115. doi: 10.1007/s13577-017-0187-5. Epub 2017 Dec 22.
9
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.miR-146a 和 miR-146b 在甲状腺乳头状癌的诊断和预后中的作用。
Oncol Rep. 2017 Nov;38(5):2735-2740. doi: 10.3892/or.2017.5994. Epub 2017 Sep 25.
10
Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.甘草查尔酮 A 通过抑制脂多糖 (LPS) 诱导的帕金森病模型中的小胶质细胞激活来防止多巴胺能神经元的丢失。
Int J Mol Sci. 2017 Sep 22;18(10):2043. doi: 10.3390/ijms18102043.